Most Read article list (ranking real-time pageviews since the publication of the article)

  
Editorial Commentary
KEYNOTE-189 5-years update: setting a backbone for the next generation clinical research in advanced non-squamous non-small cell lung cancer without oncogenic addiction
Alessandra Merlini, Anis Cipi, Giorgia Ferrari, Paolo Bironzo
Published online: 11 June 2024
PDF Full Text (20456) Peer Review File COI Form Open Access Get Permission
Editorial Commentary
Xaluritamig: a first step towards a new target, new mechanism for metastatic prostate cancer
Ruben Raychaudhuri, Michael T. Schweizer, Jessica E. Hawley, Lawrence Fong, Evan Y. Yu
Published online: 15 August 2024
PDF Full Text (17461) Peer Review File COI Form Open Access Get Permission
Review Article
First-line treatment strategies and potential prognostic factors in patients with KRAS G12C-mutant non-small cell lung cancer
Malak Alharbi, Nour Nassour, Vaishali Deenadayalan, Grace K. Dy
Published online: 26 September 2025
PDF Full Text (14621) Peer Review File COI Form Open Access Get Permission
Editorial Commentary
Assessing the UNICANCER-PRODIGE 23 trial through the lens of nonoperative management
Wini Zambare, Aron Bercz, J. Joshua Smith
Published online: 13 May 2025
PDF Full Text (13405) Peer Review File COI Form Open Access Get Permission
Editorial Commentary
Yes to adjuvant osimertinib therapy in EGFR-mutated stage IB–IIIA non-small cell lung cancer post resection, but for how long? (ADAURA/NCT02511106)
Faustine Luo, Sai-Hong Ignatius Ou, Misako Nagasaka
Published online: 21 June 2024
PDF Full Text (13362) Peer Review File COI Form Open Access Get Permission
Editorial Commentary
The Butterfly effect—will the MARIPOSA-2 study alter the trajectory of EGFR mutated non-small cell lung cancer (NSCLC)
Yuji Uehara, Aaron C. Tan
Published online: 06 June 2024
PDF Full Text (12958) Peer Review File COI Form Open Access Get Permission
Editorial Commentary
Neoadjuvant FOLFIRINOX in resectable pancreatic cancer: impact of the NORPACT-1 trial
Eva Versteijne, Geertjan van Tienhoven, Anna M. E. Bruynzeel, Johanna W. Wilmink, Marc G. Besselink, Bas Groot Koerkamp; on behalf of the Dutch Pancreatic Cancer Group
Published online: 20 December 2024
PDF Full Text (11675) Peer Review File COI Form Open Access Get Permission
Editorial Commentary
FLAURA in the real world: osimertinib in potentially trial-eligible and ineligible patients with EGFR-mutated advanced non-small cell lung cancer
Faustine X. Luo, Zhaohui Liao Arter, Sai-Hong Ignatius Ou, Misako Nagasaka
Published online: 04 December 2024
PDF Full Text (11415) Peer Review File COI Form Open Access Get Permission
Editorial Commentary
Intracranial efficacy of adagrasib in patients with KRAS G12C mutated non-small cell lung cancer (NSCLC): are results KRYSTAL clear?
Anuja Abhyankar, Grace K. Dy
Published online: 21 August 2024
PDF Full Text (11059) Peer Review File COI Form Open Access Get Permission
Editorial Commentary
Eradication of Helicobacter pylori and its impact on the incidence of gastric cancer
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Fabrício Freire de Melo
Published online: 08 May 2025
PDF Full Text (10363) Peer Review File COI Form Open Access Get Permission
Review Article
Clinical advancements in total neoadjuvant therapy for locally advanced rectal cancer: a narrative review
Angelo Pirozzi, Celine Hoyek, Naohiro Okano, Leticia Assad Maia Sandoval, Binbin Zheng-Lin, Oluseyi Abidoye, Cody Eslinger, Mohamad Bassam Sonbol, Mitesh J. Borad, Tanios S. Bekaii-Saab
Published online: 26 September 2025
PDF Full Text (9802) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Editorial Commentary
The optimum balance between efficacy and toxicity with different doses of trastuzumab deruxtecan in HER2 mutated non-small cell lung cancer in DESTINY-Lung02 trial
Saurav Verma, Jacques Raphael
Published online: 02 September 2024
PDF Full Text (9774) Peer Review File COI Form Open Access Get Permission
1 - 12 of 12 Items